Axonal ion channels from bench to bedside: A translational neuroscience perspective

Progress in Neurobiology

Volumn 89, Issue 3, 2009, Pages 288-313

  Krishnan, Arun V ^a   Lin, Cindy S Y ^a   Park, Susanna B ^a   Kiernan, Matthew C ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Axonal excitability; Na+ K+ pump; Potassium channel; Sodium channel; Threshold electrotonus

Indexed keywords

4 AMINOPYRIDINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANTICONVULSIVE AGENT; BIOLOGICAL MARKER; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHANNEL CAV2.1; CISPLATIN; ION CHANNEL; LIDOCAINE; MEXILETINE; NEUROTOXIN; OXALIPLATIN; PLATINUM; POTASSIUM CHANNEL; SODIUM ACTIVATED POTASSIUM CHANNEL; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CHANNEL; SODIUM CHANNEL BETA 1; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL TRIAL; COLORECTAL CANCER; DEMYELINATING DISEASE; DEMYELINATING NEUROPATHY; DIABETIC NEUROPATHY; DRUG TARGETING; DRUG WITHDRAWAL; ELECTROLYTE TRANSPORT; HUMAN; KIDNEY FAILURE; MEMBRANE PERMEABILITY; MULTIFOCAL MOTOR NEUROPATHY; MULTIPLE SCLEROSIS; NERVE EXCITABILITY; NERVE FIBER; NERVE FIBER MEMBRANE CONDUCTANCE; NERVE FIBER MEMBRANE POTENTIAL; NERVE FIBER REGENERATION; NEUROLOGIC DISEASE; NEURONAL CHANNELOPATHY; NEUROPATHIC PAIN; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PARESTHESIA; PERIPHERAL NEUROPATHY; PORPHYRIC NEUROPATHY; PRIORITY JOURNAL; REFRACTORY PERIOD; REVIEW; SENSORY NEUROPATHY; SPINAL CORD INJURY;

ANIMALS; AXONS; HUMANS; ION CHANNEL GATING; ION CHANNELS; MEMBRANE POTENTIALS; NERVOUS SYSTEM DISEASES; NEURAL CONDUCTION; NEURONS;

EID: 70350646922     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2009.08.002     Document Type: Review

References (373)

1. Ackil A.A., Shahani B.T., Young R.R., and Rubin N.E. Late response and sural conduction studies. Usefulness in patients with chronic renal failure. Arch. Neurol. 38 (1981) 482-485
2. +) channel kinetics on rat sensory neurons. Eur. J. Pharmacol. 406 (2000) 25-32
3. Agrawal N., Alonso A., and Ragsdale D.S. Increased persistent sodium currents in rat entorhinal cortex layer V neurons in a post-status epilepticus model of temporal lobe epilepsy. Epilepsia 44 (2003) 1601-1604
4. Ahmed C.M., Ware D.H., Lee S.C., Patten C.D., Ferrer-Montiel A.V., Schinder A.F., McPherson J.D., Wagner-McPherson C.B., Wasmuth J.J., and Evans G.A. Primary structure, chromosomal localization, and functional expression of a voltage-gated sodium channel from human brain. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 8220-8224
5. Akopian A.N., Souslova V., England S., Okuse K., Ogata N., Ure J., Smith A., Kerr B.J., McMahon S.B., Boyce S., Hill R., Stanfa L.C., Dikenson A.H., and Wood J.N. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat. Neurosci. 2 (1999) 541-548
6. + current in pyramidal neurons from rat and cat sensorimotor cortex. J. Neurosci. 13 (1993) 660-673
7. Amir R., Argoff C.E., Bennett G.J., Cummins T.R., Durieux M.E., Gerner P., Gold M.S., Porreca F., and Strichartz G.R. The role of sodium channels in chronic inflammatory and neuropathic pain. J. Pain 7 (2006) S1-S29
8. Anderson A.J., and Harvey A.L. Effects of the potassium channel blocking dendrotoxins on acetylcholine release and motor nerve terminal activity. Br. J. Pharmacol. 93 (1988) 215-221
9. Andre T., Boni C., Mounedji-Boudiaf L., Navarro M., Tabernero J., Hickish T., Topham C., Zaninelli M., Clingan P., Bridgewater J., Tabah-Fisch I., de Gramont A., and Investigators of the Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. New Engl. J. Med. 350 (2004) 2343-2351
10. Applegate C., and Burke D. Changes in excitability of human cutaneous afferents following prolonged high-frequency stimulation. Brain 112 (1989) 147-164
11. Ariyasu R.G., Nichol J.A., and Ellisman M.H. Localization of sodium/potassium adenosine triphosphatase in multiple cell types of the murine nervous system with antibodies raised against the enzyme from kidney. J. Neurosci. 5 (1985) 2581-2596
12. Arroyo E.J., Xu Y.T., Zhou L., Messing A., Peles E., Chiu S.Y., and Scherer S.S. Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, and Caspr. J. Neurocytol. 28 (1999) 333-347
13. Baker M., Bostock H., Grafe P., and Martius P. Function and distribution of three types of rectifying channel in rat spinal root myelinated axons. J. Physiol. 383 (1987) 45-67
14. Baker M.D. Axonal flip-flops and oscillators. Trends Neurosci. 23 (2000) 514-519
15. Baker M.D., and Bostock H. Low-threshold, persistent sodium current in rat large dorsal root ganglion neurons in culture. J. Neurophysiol. 77 (1997) 1503-1513
16. + currents in sensory neurons. J. Neurophysiol. 80 (1998) 2538-2549
17. Baker M.D., and Bostock H. The pH dependence of late sodium current in large sensory neurons. Neuroscience 92 (1999) 1119-1130
18. Baloh R.W., Yue Q., Furman J.M., and Nelson S.F. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann. Neurol. 41 (1997) 8-16
19. Barrett E.F., and Barrett J.N. Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J. Physiol. 323 (1982) 117-144
20. Bean B.P. The molecular machinery of resurgent sodium current revealed. Neuron 45 (2005) 185-187
21. Bechtold D.A., Kapoor R., and Smith K.J. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann. Neurol. 55 (2004) 607-616
22. Bechtold D.A., and Smith K.J. Sodium-mediated axonal degeneration in inflammatory demyelinating disease. J. Neurol. Sci. 233 (2005) 27-35
23. Bechtold D.A., Yue X., Evans R.M., Davies M., Gregson N.A., and Smith K.J. Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide. Brain 128 (2005) 18-28
24. Becker D., Viljoen D., and Kramer S. The inhibition of red cell and brain ATPase by delta-aminolaevulinic acid. Biochim. Biophys. Acta 225 (1971) 26-34
25. + channels in frog peripheral myelinated axons. Gen. Physiol. Biophys. 25 (2006) 263-276
26. Bergmans J. The Physiology of Single Human Nerve Fibres (1970), University of Louvain, Vander, Belgium
27. Bergmans J. Repetitive activity induced in single motor axons: a model for pathological repetitive activity. In: Cup W.J., and Ochoa J. (Eds). Abnormal Nerves and Muscles as Impulse Generators (1982), Oxford University Press, New York 393-419
28. 2+. Trends Neurosci. 28 (2005) 422-428
29. Birch B.D., Kocsis J.D., Di Gregorio F., Bhisitkul R.B., and Waxman S.G. A voltage- and time-dependent rectification in rat dorsal spinal root axons. J. Neurophysiol. 66 (1991) 719-728
30. Bittar E.E. Maia muscle fibre as a model for the study of uraemic toxicity. Nature 214 (1967) 310-312
31. Boland R.A., Bostock H., and Kiernan M.C. Plasticity of lower limb motor axons after cervical cord injury. Clin. Neurophysiol. 120 (2009) 204-209
32. Bostock H. The strength-duration relationship for excitation of myelinated nerve: computed dependence on membrane parameters. J. Physiol. 341 (1983) 59-74
33. Bostock H., and Baker M. Evidence for two types of potassium channel in human motor axons in vivo. Brain Res. 462 (1988) 354-358
34. Bostock H., and Bergmans J. Post-tetanic excitability changes and ectopic discharges in a human motor axon. Brain 117 (1994) 913-928
35. Bostock H., and Grafe P. Activity-dependent excitability changes in normal and demyelinated rat spinal root axons. J. Physiol. 365 (1985) 239-257
36. Bostock H., and Rothwell J.C. Latent addition in motor and sensory fibres of human peripheral nerve. J. Physiol. 498 (1997) 277-294
37. Bostock H., Sears T.A., and Sherratt R.M. The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres. J. Physiol. 313 (1981) 301-315
38. Bostock H., Baker M., Grafe P., and Reid G. Changes in excitability and accommodation of human motor axons following brief periods of ischaemia. J. Physiol. 441 (1991) 513-535
39. Bostock H., Baker M., and Reid G. Changes in excitability of human motor axons underlying post-ischaemic fasciculations: evidence for two stable states. J. Physiol. 441 (1991) 537-557
40. Bostock H., Burke D., and Hales J.P. Differences in behaviour of sensory and motor axons following release of ischaemia. Brain 117 (1994) 225-234
41. Bostock H., Sharief M.K., Reid G., and Murray N.M. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 118 (1995) 217-225
42. Bostock H., Cikurel K., and Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 21 (1998) 137-158
43. Boyle M.E.T., Berglund E.O., Murai K.K., Weber L., Peles E., and Ranscht B. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron 30 (2001) 385-397
44. Brau M.E., Nau C., Hempelmann G., and Vogel W. Local anesthetics potently block a potential insensitive potassium channel in myelinated nerve. J. Gen. Physiol. 105 (1995) 485-505
45. Brismar T. Potential clamp analysis of membrane currents in rat myelinated nerve fibres. J. Physiol. 298 (1980) 171-184
46. Brismar T. Abnormal Na-currents in diabetic rat nerve nodal membrane. Diabetes Med. 10 (1993) 110S-112S
47. Brismar T., and Tegner R. Experimental uremic neuropathy. Part 2. Sodium permeability decrease and inactivation in potential clamped nerve fibers. J. Neurol. Sci. 65 (1984) 37-45
48. Brodu V., Elstob P.R., and Gould A.P. EGF receptor signaling regulates pulses of cell delamination from the Drosophila ectoderm. Dev. Cell 7 (2004) 885-895
49. + current in a vertebrate neurone. Nature 283 (1980) 673-676
50. Brown H., and DiFrancesco D. Voltage-clamp investigations of membrane currents underlying pace-maker activity in rabbit sino-atrial node. J. Physiol. 308 (1980) 331-351
51. Browne D.L., Gancher S.T., Nutt J.G., Brunt E.R., Smith E.A., Kramer P., and Litt M. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat. Genet. 8 (1994) 136-140
52. v1.6 voltage-gated sodium channel from the human brain. Mol. Brain Res. 103 (2002) 80-90
53. Burke D. Microneurography, impulse conduction, and paresthesias. Muscle Nerve 16 (1993) 1025-1032
54. Burke D., Miller T.A., Kiernan M.C., and Mogyoros I. Activity-dependent modulation of excitability. Muscle Nerve 18 (1995) 675-677
55. Burke D., Kiernan M.C., Mogyoros I., and Bostock H. Susceptibility to conduction block: difference in the biophysical properties of cutaneous afferents and motor axons. In: Kimura J., and Kaji R. (Eds). Physiology of ALS and Related Disorders (1997), Elsevier, Amsterdam 43-53
56. Burke D., Mogyoros I., Vagg R., and Kiernan M.C. Quantitative description of the voltage dependence of axonal excitability in human cutaneous afferents. Brain 121 (1998) 1975-1983
57. Burke D., Kiernan M.C., and Bostock H. Excitability of human axons. Clin. Neurophysiol. 112 (2001) 1575-1585
58. Burke D., Howells J., Trevillion L., McNulty P.A., Jankelowitz S.K., and Kiernan M.C. Threshold behaviour of human axons explored using subthreshold perturbations to membrane potential. J. Physiol. 587 (2009) 491-504
59. Caffrey J.M., Eng J.A., Black S.G., Waxman S.G., and Kocsis J.D. Three types of sodium channels in adult rat dorsal root ganglia. Brain Res. 592 (1992) 283-297
60. Caldwell J.H., Schaller K.L., Lasher R.S., Peles E., and Levinson S.R. Sodium channel Na(v)1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5616-5620
61. Cappelen-Smith C., Kuwabara S., Lin C.S., Mogyoros I., and Burke D. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy. Ann. Neurol. 48 (2000) 826-832
62. Cappelen-Smith C., Kuwabara S., Lin C.S., and Burke D. Abnormalities of axonal excitability are not generalized in early multifocal motor neuropathy. Muscle Nerve 26 (2002) 769-776
63. Carr D.B., Day M., Cantrell A.R., Held J., Scheuer T., Catterall W.A., and Surmeier D.J. Transmitter modulation of slow, activity-dependent alterations in sodium channel availability endows neurons with a novel form of cellular plasticity. Neuron 39 (2003) 793-806
64. Catterall W.A. Cellular and molecular biology of voltage-gated sodium channels. Physiol. Rev. 72 (1992) S15-S48
65. Catterall W.A., Goldin A.L., and Waxman S.G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 57 (2005) 397-409
66. Charcot J.M. Leçons du mardi (1887-1888) and Leçon du mardi (1888-1889) (1889), Bureaux du Progrès Médical, Paris
67. Chen C., Bharucha V., Chen Y., Westenbroek R.E., Brown A., Malhotra J.D., Jones D., Avery C., Gillespie P.J., Kazen-Gillespie K.A., Kazarinova-Noyes K., Shrager P., Saunders T.L., Macdonald R.L., Ransom B.R., Scheuer T., Catterall W.A., and Isom L.L. Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 17072-17077
68. Chiu S.Y., and Ritchie J.M. Potassium channels in nodal and internodal axonal membrane of mammalian myelinated fibres. Nature 284 (1980) 170-171
69. Chiu S.Y., and Ritchie J.M. On the physiological role of internodal potassium channels and the security of conduction in myelinated nerve fibres. Proc. R. Soc. Lond. B Biol. Sci. 220 (1984) 415-422
70. Chiu S.Y., Ritchie J.M., Rogart R.B., and Stagg D. A quantitative description of membrane currents in rabbit myelinated nerve. J. Physiol. 292 (1979) 149-166
71. Clay J.R. On the persistent sodium current in squid giant axons. J. Neurophysiol. 89 (2003) 640-644
72. + channel from human brain. Ann. N. Y. Acad. Sci. 868 (1999) 80-83
73. Cole K.S., and Curtis A.J. Electrical impedance of the squid giant axon during activity. J. Gen. Physiol. 22 (1938) 649-670
74. Constanti A., and Galvan M. Fast inward-rectifying current accounts for anomalous rectification in olfactory cortex neurones. J. Physiol. 335 (1983) 153-178
75. Cox J.J., Reimann F., Nicholas A.K., Thornton G., Roberts E., Springell K., Karbani G., Jafri H., Mannan J., Raashid Y., Al-Gazali L., Hamamy H., Valente E.M., Gorman S., Williams R., McHale D.P., Wood J.N., Gribble F.M., and Woods C.G. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444 (2006) 894-898
76. v1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain 127 (2004) 294-303
77. Crill W.E. Persistent sodium current in mammalian central neurons. Ann. Rev. Physiol. 58 (1996) 349-362
78. Cummins T.R., Dib-Hajj S.D., Black J.A., Akopian A.N., Wood J.N., and Waxman S.G. A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J. Neurosci. 19 (1999) RC43
79. v1.3 sodium channels: Rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons. J. Neurosci. 21 (2001) 5952-5961
80. + pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33 (2003) 192-196
81. de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., Boni C., Cortes-Funes H., Cervantes A., Freyer G., Papamichael D., Le Bail N., Louvet C., Hendler D., de Braud F., Wilson C., Morvan F., and Bonetti A. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol. 18 (2000) 2938-2947
82. + channel. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12272-12277
83. Devaux J.J., and Scherer S.S. Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA. J. Neurosci. 25 (2005) 1470-1480
84. + channel immunolocalization in peripheral mammalian axons and changes following nerve injury and neuroma formation. J. Neurosci. 13 (1993) 1976-1992
85. Dib-Hajj S.D., Tyrrell L., Black J.A., and Waxman S.G. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 8963-8968
86. Dib-Hajj S.D., Fjell J., Cummins T.R., Zheng Z., Fried K., LaMotte R., Black J.A., and Waxman S.G. Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain. Pain 83 (1999) 591-600
87. Dib-Hajj S.D., Cummins T.R., Black J.A., and Waxman S.G. From genes to pain: Na v 1.7 and human pain disorders. Trends Neurosci. 30 (2007) 555-563
88. DiFrancesco D. A new interpretation of the pace-maker current in calf Purkinje fibres. J. Physiol. 314 (1981) 359-376
89. v1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons. J. Physiol. 550 (2003) 739-752
90. v1.6-null mice. J. Neurophysiol. 92 (2004) 726-733
91. Drenth J.P.H., and Waxman S.G. Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. J. Clin. Invest. 117 (2007) 3603-3609
92. Dubois J.M. Evidence for the existence of three types of potassium channels in the frog Ranvier node membrane. J. Physiol. 318 (1981) 297-316
93. Duchen M.R. Effects of metabolic inhibition on the membrane properties of isolated mouse primary sensory neurones. J. Physiol. 424 (1990) 387-409
94. v1.1 is predominantly expressed in nodes of Ranvier and axon initial segments. Mol. Cell. Neurosci. 39 (2008) 180-192
95. Elliott A.A., and Elliott J.R. Characterization of TTX-sensitive and TTX-resistant sodium currents in small cells from adult rat dorsal root ganglia. J. Physiol. 463 (1993) 39-56
96. Eng D.L., Gordon T.R., Kocsis J.D., and Waxman S.G. Development of 4-AP and TEA sensitivities in mammalian myelinated nerve fibers. J. Neurophysiol. 60 (1988) 2168-2179
97. Eng D.L., Gordon T.R., Kocsis J.D., and Waxman S.G. Current-clamp analysis of a time-dependent rectification in rat optic nerve. J. Physiol. 421 (1990) 185-202
98. England J.D., Gamboni F., Ferguson M.A., and Levinson S.R. Sodium channels accumulate at the tips of injured axons. Muscle Nerve 17 (1994) 593-598
99. +, and adenosine triphosphate in isolated brain synaptosomes. J. Gen. Physiol. 95 (1990) 591-616
100. Escayg A., MacDonald B.T., Meisler M.H., Baulac S., Huberfeld G., An-Gourfinkel I., Brice A., LeGuern E., Moulard B., Chaigne D., Buresi C., and Malafosse A. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat. Genet. 24 (2000) 343-345
101. Fang X., Djouhri L., Black J.A., Dib-Hajj S.D., Waxman S.D., and Lawson S.N. The presence and role of the tetrodotoxin-resistant sodium channel Na(v)1.9 (NaN) in nociceptive primary afferent neurons. J. Neurosci. 22 (2002) 7425-7433
102. Felts P.A., Kapoor R., and Smith K.J. A mechanism for ectopic firing in central demyelinated axons. Brain 118 (1995) 1225-1231
103. Felts P.A., Yokoyama S., Dib-Hajj S., Black J.A., and Waxman S.G. Sodium channel [alpha]-subunit mRNAs I, II, III, NaG, Na6 and hNE (PN1): different expression patterns in developing rat nervous system. Mol. Brain Res. 45 (1997) 71-82
104. Fertleman C.R., Baker M.D., Parker K.A., Moffatt S., Elmslie F.V., Abrahamsen B., Ostman J., Klugbauer N., Wood J.N., Gardiner R.M., and Rees M. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52 (2006) 767-774
105. +-ATPase activity in diabetes mellitus type I. Clin. Sci. 98 (2000) 283-290
106. French C.R., Sah P., Buckett K.J., and Gage P.W. A voltage-dependent persistent sodium current in mammalian hippocampal neurons. J. Gen. Physiol. 95 (1990) 1139-1157
107. Fujiwara T., Sugawara T., Mazaki-Miyazaki E., Takahashi Y., Fukushima K., Watanabe M., Hara K., Morikawa T., Yagi K., Yamakawa K., and Inoue Y. Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain 126 (2003) 531-546
108. Gamelin E., Gamelin L., Bossi L., and Quasthoff S. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Semin. Oncol. 29 (2002) 21-33
109. Goldin A.L. Resurgence of sodium channel research. Ann. Rev. Physiol. 63 (2001) 871-894
110. Goldin A.L., Barchi R.L., Caldwell J.H., Hofmann F., Howe J.R., Hunter J.C., Kallen R.G., Mandel G., Meisler M.H., Netter Y.B., Noda M., Tamkun M.M., Waxman S.G., Wood J.N., and Catterall W.A. Nomenclature of voltage-gated sodium channels. Neuron 28 (2000) 365-368
111. +)-ATPase) activity in rat optic nerve. Neuroscience 37 (1990) 829-837
112. Grafe P., Bostock H., and Schneider U. The effects of hyperglycaemic hypoxia on rectification in rat dorsal root axons. J. Physiol. 480 (1994) 297-307
113. Grafe P., Quasthoff S., Grosskreutz J., and Alzheimer C. Function of the hyperpolarization-activated inward rectification in nonmyelinated peripheral rat and human axons. J. Neurophysiol. 77 (1997) 421-426
114. Greene D.A. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing. Metab. Clin. Exp. 35 (1986) 60-65
115. Greene D.A. Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve. Drugs 32 (1986) 6-14
116. Greene D.A., and Lattimer S.A. Impaired energy utilization and Na-K-ATPase in diabetic peripheral nerve. Am. J. Physiol. 246 (1984) E311-E318
117. Greene D.A., Lattimer S.A., and Sima A.A. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. New Engl. J. Med. 316 (1987) 599-606
118. +-ATPase regulation involved in pathogenesis of diabetic neuropathy?. Diabetes 37 (1988) 688-693
119. Grieco T.M., Malhotra J.D., Chen C., Isom L.L., and Raman I.M. Open-channel block by the cytoplasmic tail of sodium channel beta4 as a mechanism for resurgent sodium current. Neuron 45 (2005) 233-244
120. v1.6-null Purkinje neurons by slowing sodium channel inactivation with beta-pompilidotoxin. J. Neurosci. 24 (2004) 35-42
121. Grolleau F., Gamelin L., Boisdron-Celle M., Lapied B., Pelhate M., and Gamelin E. A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J. Neurophysiol. 85 (2001) 2293-2297
122. Grosskreutz J., Lin C.S.-Y., Mogyoros I., and Burke D. Changes in excitability indices of cutaneous afferents produced by ischaemia in human subjects. J. Physiol. 518 (1999) 301-314
123. Grothey A. Oxaliplatin-safety profile: neurotoxicity. Semin. Oncol. 30 (2003) 5-13
124. Grunberger G., Qiang X., Li Z., Mathews S.T., Sbrissa D., Shisheva A., and Sima A.A. Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 44 (2001) 1247-1257
125. Gurnett C.A., and Campbell K.P. Transmembrane auxiliary subunits of voltage-dependent ion channels. J. Biol. Chem. 271 (1996) 27975-27978
126. Gutman G.A., Chandy K.G., Grissmer S., Lazdunski M., McKinnon D., Pardo L.A., Robertson G.A., Rudy B., Sanguinetti M.C., Stuhmer W., and Wang X. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 57 (2005) 473-508
127. Halliwell J.V., and Adams P.R. Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res. 250 (1982) 71-92
128. Hammond C. Ionic fluxes across the neuronal plasma membrane. In: Hammond C. (Ed). Cellular and Molecular Neurobiology (2001), Academic Press, London 36-56
129. + action potentials. In: Hammond C. (Ed). Cellular and Molecular Neurobiology (2001), Academic Press, London 69-109
130. v1.7. Ann. Neurol. 59 (2006) 553-558
131. Hanck D.A., Makielski J.C., and Sheets M.F. Kinetic effects of quaternary lidocaine block of cardiac sodium channels: a gating current study. J. Gen. Physiol. 103 (1994) 19-43
132. Hausheer F.H., Schilsky R.L., Bain S., Berghorn E.J., and Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin. Oncol. 33 (2006) 15-49
133. Herrick A.L., and McColl K.E.L. Acute intermittent porphyria. Best Pract. Res. Clin. Gastroenterol. 19 (2005) 235-249
134. v1.7 sodium channels in mouse spinal sensory neurons. J. Physiol. 551 (2003) 741-750
135. Hess K., Eames R.A., Darveniza P., and Gilliatt R.W. Acute ischaemic neuropathy in the rabbit. J. Neurol. Sci. 44 (1979) 19-43
136. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J. Gen. Physiol. 69 (1977) 497-515
137. Hille B. Ionic Channels of Excitable Membranes (1992), Sinauer Associates, Sunderland
138. Hodgkin A.L., and Huxley A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 117 (1952) 500-544
139. Hodgkin A.L., and Katz B. The effects of sodium ions on the electrical activity of the giant axons of the squid. J. Physiol. 108 (1949) 37-77
140. Hodgkin A.L., and Keynes R.D. Movement of cations during recovery in nerve. Symp. Soc. Exp. Biol. 8 (1954) 423-437
141. Hodgkin A.L., and Keynes R.D. Active transport of cations in giant axons from Sepia and Logilo. J. Physiol. 128 (1955) 28-60
142. +) ATPase, and glutathione in diabetic rats. Eur. J. Pharmacol. 397 (2000) 335-341
143. 2+ binding and channel opening in large conductance (BK) potassium channels. J. Gen. Physiol. 120 (2002) 267-305
144. Hutchison III C.A., Phillips S., Edgell M.H., Gillam S., Jahnke P., and Smith M. Mutagenesis at a specific position in a DNA sequence. J. Biol. Chem. 253 (1978) 6551-6560
145. Isbister G.K., and Kiernan M.C. Neurotoxic marine poisoning. Lancet Neurol. 4 (2005) 219-228
146. Isom L.L. Sodium channel beta subunits: anything but auxiliary. Neuroscientist 7 (2001) 42-54
147. Ito M., and Oshima T. Electrical behaviour of the motoneurone membrane during intracellularly applied current steps. J. Physiol. 180 (1965) 607-635
148. Jahnsen H. Extracellular activation and membrane conductances of neurones in the guinea-pig deep cerebellar nuclei in vitro. J. Physiol. 372 (1986) 149-168
149. Jen J., Wan J., Graves M., Yu H., Mock A.F., Coulin C.J., Kim G., Yue Q., Papazian D.M., and Baloh R.W. Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology 57 (2001) 1843-1848
150. Jiang Y.-M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., Niwa J.-I., Tanaka F., Doyu M., Yoshida M., Hashizume Y., and Sobue G. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 57 (2005) 236-251
151. Jiang Y.-Q., Xing G.-G., Wang S.-L., Tu H.-Y., Chi Y.-N., Li J., Liu F.-Y., Han J.-S., and Wan Y. Axonal accumulation of hyperpolarization-activated cyclic nucleotide-gated cation channels contributes to mechanical allodynia after peripheral nerve injury in rat. Pain 137 (2008) 495-506
152. Jonas P., Brau M.E., Hermsteiner M., and Vogel W. Single-channel recording in myelinated nerve fibers reveals one type of Na channel but different K channels. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7238-7242
153. Jonas P., Koh D.S., Kampe K., Hermsteiner M., and Vogel W. ATP-sensitive and Ca-activated K channels in vertebrate axons: novel links between metabolism and excitability. Pflugers Arch. 418 (1991) 68-73
154. Jones R.E., Heron J.R., Foster D.H., Snelgar R.S., and Mason R.J. Effects of 4-aminopyridine in patients with multiple sclerosis. J. Neurol. Sci. 60 (1983) 353-362
155. Judge S.I.V., and Bever Jr. C.T. Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol. Ther. 111 (2006) 224-259
156. Kahlig K.M., Misra S.N., and George Jr. A.L. Impaired inactivation gate stabilization predicts increased persistent current for an epilepsy-associated SCN1A mutation. J. Neurosci. 26 (2006) 10958-10966
157. Kaji R., Bostock H., Kohara N., Murase N., Kimura J., and Shibasaki H. Activity-dependent conduction block in multifocal motor neuropathy. Brain 123 (2000) 1602-1611
158. Kaji R., and Sumner A.J. Ouabain reverses conduction disturbances in single demyelinated nerve fibers. Neurology 39 (1989) 1364-1368
159. Kallen R.G., Sheng Z.H., Yang J., Chen L., Rogart R.B., and Barchi R.L. Primary structure and expression of a sodium channel characteristic of denervated and immature rat skeletal muscle. Neuron 4 (1990) 233-242
160. Kanai K., Kuwabara S., Arai K., Sung J.Y., Ogawara K., and Hattori T. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain 126 (2003) 965-973
161. Kanai K., Kuwabara S., Misawa S., Tamura N., Ogawara K., Nakata M., Sawai S., Hattori T., and Bostock H. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 129 (2006) 953-962
162. Kapoor R., Davies M., Blaker P.A., Hall S.M., and Smith K.J. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann. Neurol. 53 (2003) 174-180
163. Karimi-Abdolrezaee S., Eftekharpour E., and Fehlings M.G. Temporal and spatial patterns of Kv1.1 and Kv1.2 protein and gene expression in spinal cord white matter after acute and chronic spinal cord injury in rats: implications for axonal pathophysiology after neurotrauma. Eur. J. Neurosci. 19 (2004) 577-589
164. Kauppinen R. Porphyrias. Lancet 365 (2005) 241-252
165. Kiernan M.C., and Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 123 (2000) 2542-2551
166. Kiernan M.C., and Krishnan A.V. The pathophysiology of oxaliplatin-induced neurotoxicity. Curr. Med. Chem. 13 (2006) 2901-2907
167. Kiernan M.C., Mogyoros I., and Burke D. Changes in excitability and impulse transmission following prolonged repetitive activity in normal subjects and patients with a focal nerve lesion. Brain 119 (1996) 2029-2037
168. Kiernan M.C., Mogyoros I., and Burke D. Differences in the recovery of excitability in sensory and motor axons of human median nerve. Brain 119 (1996) 1099-1105
169. Kiernan M.C., Mogyoros I., Hales J.P., Gracies J.M., and Burke D. Excitability changes in human cutaneous afferents induced by prolonged repetitive axonal activity. J. Physiol. 500 (1997) 255-264
170. Kiernan M.C., Burke D., Andersen K.V., and Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 23 (2000) 399-409
171. Kiernan M.C., Lin C.S., Andersen K.V., Murray N.M., and Bostock H. Clinical evaluation of excitability measures in sensory nerve. Muscle Nerve 24 (2001) 883-892
172. Kiernan M.C., Guglielmi J.M., Kaji R., Murray N.M., and Bostock H. Evidence for axonal membrane hyperpolarization in multifocal motor
173. Kiernan M.C., Walters R.J., Andersen K.V., Taube D., Murray N.M., and Bostock H. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia. Brain 125 (2002) 1366-1378
174. +) current in adult rat small sensory neurons. Neuroscience 119 (2003) 653-660
175. Kiernan M.C., Lin C.S.-Y., and Burke D. Differences in activity-dependent hyperpolarization in human sensory and motor axons. J. Physiol. 558 (2004) 341-349
176. Kiernan M.C., Isbister G.K., Lin C.S.Y., Burke D., and Bostock H. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann. Neurol. 57 (2005) 339-348
177. + channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability. Brain 128 (2005) 1841-1846
178. Kim C.H., Oh Y., Chung J.M., and Chung K. Changes in three subtypes of tetrodotoxin sensitive sodium channel expression in the axotomized dorsal root ganglion in the rat. Neurosci. Lett. 323 (2002) 125-128
179. Kirshblum S., Lim S., Garstang S., and Millis S. Electrodiagnostic changes of the lower limbs in subjects with chronic complete cervical spinal cord injury. Arch. Phys. Med. Rehabil. 82 (2001) 604-607
180. Kitano Y., Kuwabara S., Misawa S., Ogawara K., Kanai K., Kikkawa Y., Yagui K., and Hattori T. The acute effects of glycemic control on axonal excitability in human diabetics. Ann. Neurol. 56 (2004) 462-467
181. Kocsis J.D., Bowe C.M., and Waxman S.G. Different effects of 4-aminopyridine on sensory and motor fibers: pathogenesis of paresthesias. Neurology 36 (1986) 117-120
182. Koester J. Voltage gated ion channels and generation of the action potential. In: Kandel E.R., Schwartz J.H., and Jessell T.M. (Eds). Principles of Neural Science (1991), Elsevier Science, London 104-118
183. Koh D.S., Jonas P., Brau M.E., and Vogel W. A TEA-insensitive flickering potassium channel active around the resting potential in myelinated nerve. J. Membr. Biol. 130 (1992) 149-162
184. + channels localized in the nodal region of myelinated axons of Xenopus. J. Physiol. 479 (1994) 183-197
185. Krishnan A.V., and Kiernan M.C. Altered nerve excitability properties in established diabetic neuropathy. Brain 128 (2005) 1178-1187
186. Krishnan A.V., and Kiernan M.C. Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve 35 (2007) 273-290
187. Krishnan A.V., Lin C.S.-Y., and Kiernan M.C. Nerve excitability properties in lower limb motor axons: evidence for a length-dependent gradient. Muscle Nerve 29 (2004) 645-655
188. Krishnan A.V., Colebatch J.G., and Kiernan M.C. Hypokalemia induces activity-dependent conduction block. Neurology 65 (2005) 1309-1312
189. Krishnan A.V., Goldstein D., Friedlander M., and Kiernan M.C. Oxaliplatin-induced neurotoxicity and the development of neuropathy. Muscle Nerve 32 (2005) 51-60
190. Krishnan A.V., Phoon R.K., Pussell B.A., Charlesworth J.A., Bostock H., and Kiernan M.C. Altered motor nerve excitability in end-stage kidney disease. Brain 128 (2005) 2164-2174
191. + channel function in vivo. Clin. Cancer Res. 12 (2006) 4481-4484
192. Krishnan A.V., Phoon R.K., Pussell B.A., Charlesworth J.A., Bostock H., and Kiernan M.C. Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease. Brain 129 (2006) 1585-1592
193. + pump function and activity-dependent excitability changes in end-stage kidney disease. Clin. Neurophysiol. 117 (2006) 992-997
194. Krishnan A.V., Phoon R.K., Pussell B.A., Charlesworth J.A., and Kiernan M.C. Sensory nerve excitability and neuropathy in end-stage kidney disease. J. Neurol. Neurosurg. Psychiatry 77 (2006) 548-551
195. Krishnan A.V., Bostock H., Ip J., Hayes M., Watson S.R., and Kiernan M.C. Axonal function in a family with episodic ataxia type 2 due to a novel mutation. J. Neurol. 255 (2008) 750-755
196. + pump dysfunction in diabetic neuropathy. Brain 131 (2008) 1209-1216
197. Krishnan A.V., Lin C.S., Park S.B., and Kiernan M.C. Assessment of nerve excitability in toxic and metabolic neuropathies. J. Peripher. Nerv. Syst. 13 (2008) 7-26
198. Krnjevic L., and Miledi R. Presynaptic failure of neuromuscular propagation in rats. J. Physiol. 149 (1959) 1-22
199. Kugelberg E. Accommodation in human nerves and its significance for the symptoms in circulatory disturbances and tetany. Acta Physiol. Scand. 8 (1944) 1-105
200. + channels. Mol. Pharmacol. 54 (1998) 712-721
201. Kuwabara S., Kanai K., Sung J.Y., Ogawara K., Hattori T., Burke D., and Bostock H. Axonal hyperpolarization associated with acute hypokalemia: multiple excitability measurements as indicators of the membrane potential of human axons. Muscle Nerve 26 (2002) 283-287
202. Kuwabara S., Misawa S., Tamura N., Kanai K., Hiraga A., Ogawara K., Nakata M., and Hattori T. The effects of mexiletine on excitability properties of human median motor axons. Clin. Neurophysiol. 116 (2005) 284-289
203. + current. J. Pharmacol. Exp. Ther. 284 (1998) 228-237
204. Land S.R., Kopec J.A., Cecchini R.S., Ganz P.A., Wieand H.S., Colangelo L.H., Murphy K., Kuebler J.P., Seay T.E., Needles B.M., Bearden III J.D., Colman L.K., Lanier K.S., Pajon Jr. E.R., Cella D., Smith R.E., O'Connell M.J., Costantino J.P., and Wolmark N. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J. Clin. Oncol. 25 (2007) 2205-2211
205. + channel S4. Neuron 16 (1996) 387-397
206. Leech C.A., and Stanfield P.R. Inward rectification in frog skeletal muscle fibres and its dependence on membrane potential and external potassium. J. Physiol. 319 (1981) 295-309
207. Lehky T., Leonard G.D., Wilson R.H., Grem J.L., and Floeter M.K. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve 29 (2004) 387-392
208. Lewis R.A., Sumner A.J., Brown M.J., and Asbury A.K. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 32 (1982) 958-964
209. Lin C.S.-Y., Mogyoros I., and Burke D. Recovery of excitability of cutaneous afferents in the median and sural nerves following activity. Muscle Nerve 23 (2000) 763-770
210. Lin C.S., Grosskreutz J., and Burke D. Sodium channel function and the excitability of human cutaneous afferents during ischaemia. J. Physiol. 538 (2002) 435-446
211. Lin C.S., Kuwabara S., Cappelen-Smith C., and Burke D. Responses of human sensory and motor axons to the release of ischaemia and to hyperpolarizing currents. J. Physiol. 541 (2002) 1025-1039
212. Lin, C.S., Kiernan, M.C., Burke, D., Bostock, H., 2006. Assessment of nerve excitability properties in peripheral nerve disease. In: Daube, J., Mauguiere, F. (Eds.). Handbook of Clinical Neurophysiology. In: Kimura, J. (Ed.). Clinical Neurophysiology of Peripheral Nerve Diseases. Elsevier, Amsterdam.
213. Lin C.S.-Y., Macefield V.G., Elam M., Wallin B.G., Engel S., and Kiernan M.C. Axonal changes in spinal cord injured patients distal to the site of injury. Brain 130 (2007) 985-994
214. Lin C.S., Krishnan A.V., Lee M.-J., Zagami A.S., You H.-L., Yang C.-C., Bostock H., and Kiernan M.C. Nerve function and dysfunction in acute intermittent porphyria. Brain 131 (2008) 2510-2519
215. v1.3-like immunoreactivity in the adult rat central nervous system. Brain Res. 960 (2003) 132-141
216. Liu X., and Stan Leung L. Sodium-activated potassium conductance participates in the depolarizing afterpotential following a single action potential in rat hippocampal CA1 pyramidal cells. Brain Res. 1023 (2004) 185-192
217. Lorente De Nó R. A study of nerve physiology. Studies from the Rockefeller Institute for Medical Research. Part I vol. 131 (1947) pp. 1-496
218. Lossin C., Wang D.W., Rhodes T.H., Vanoye C.G., and George Jr. A.L. Molecular basis of an inherited epilepsy. Neuron 34 (2002) 877-884
219. Maccaferri G., Mangoni M., Lazzari A., and DiFrancesco D. Properties of the hyperpolarization-activated current in rat hippocampal CA1 pyramidal cells. J. Neurophysiol. 69 (1993) 2129-2136
220. Macefield G., and Burke D. Paraesthesiae and tetany induced by voluntary hyperventilation. Increased excitability of human cutaneous and motor axons. Brain 114 (1991) 527-540
221. Mackel R., and Brink E. Conduction of neural impulses in diabetic neuropathy. Clin. Neurophysiol. 114 (2003) 248-255
222. Madan P., Kalra O.P., Agarwal S., and Tandon O.P. Cognitive impairment in chronic kidney disease. Nephrol. Dial. Transplant. 22 (2007) 440-444
223. +) current in entorhinal cortex neurons. J. Neurosci. 19 (1999) 7334-7341
224. Marconi R., De Fusco M., Aridon P., Plewnia K., Rossi M., Carapelli S., Ballabio A., Morgante L., Musolino R., Epifanio A., Micieli G., De Michele G., and Casari G. Familial hemiplegic migraine type 2 is linked to 0.9 Mb region on chromosome 1q23. Ann. Neurol. 53 (2003) 376-381
225. Marrion N.V. Control of M-current. Ann. Rev. Physiol. 59 (1997) 483-504
226. +)-ATPase in internodal axolemma of myelinated fibers of rat sciatic and optic nerves. J. Neurochem. 57 (1991) 184-192
227. + channels. J. Neurophysiol. 72 (1994) 349-359
228. Maurer K., Hopf H.C., and Lowitzsch K. Hypokalemia shortens relative refractory period of peripheral sensory nerves in man. J. Neurol. 216 (1977) 67-71
229. Mayer M.L., and Westbrook G.L. A voltage-clamp analysis of inward (anomalous) rectification in mouse spinal sensory ganglion neurones. J. Physiol. 340 (1983) 19-45
230. McCormick D.A., and Pape H.C. Properties of a hyperpolarization-activated cation current and its role in rhythmic oscillation in thalamic relay neurones. J. Physiol. 431 (1990) 291-318
231. McKay O.M., Krishnan A.V., Davis M., and Kiernan M.C. Activity-induced weakness in recessive myotonia congenita with a novel (696+1G>A) mutation. Clin. Neurophysiol. 117 (2006) 2064-2068
232. Meadows L.S., Malhotra J., Loukas A., Thyagarajan V., Kazen-Gillespie K.A., Koopman M.C., Kriegler S., Isom L.L., and Ragsdale D.S. Functional and biochemical analysis of a sodium channel beta1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1. J. Neurosci. 22 (2002) 10699-10709
233. Miller T.A., Kiernan M.C., Mogyoros I., and Burke D. Activity-dependent changes in impulse conduction in normal human cutaneous axons. Brain 118 (1995) 1217-1224
234. Misawa S., Kuwabara S., Kanai K., Tamura N., Hiraga A., Nakata M., Ogawara K., and Hattori T. Axonal potassium conductance and glycemic control in human diabetic nerves. Clin. Neurophysiol. 116 (2005) 1181-1187
235. Misawa S., Kuwabara S., Ogawara K., Kitano Y., and Hattori T. Strength-duration properties and glycemic control in human diabetic motor nerves. Clin. Neurophysiol. 116 (2005) 254-258
236. Misawa S., Kuwabara S., Ogawara K., Kitano Y., Yagui K., and Hattori T. Hyperglycemia alters refractory periods in human diabetic neuropathy. Clin. Neurophysiol. 115 (2004) 2525-2529
237. Mogyoros I., Kiernan M.C., and Burke D. Strength-duration properties of human peripheral nerve. Brain 119 (1996) 439-447
238. Mogyoros I., Kiernan M.C., and Burke D. Strength-duration properties of sensory and motor axons in carpal tunnel syndrome. Muscle Nerve 20 (1997) 508-510
239. Mogyoros I., Kiernan M.C., Burke D., and Bostock H. Excitability changes in human sensory and motor axons during hyperventilation and ischaemia. Brain 120 (1997) 317-325
240. Mogyoros I., Bostock H., and Burke D. Mechanisms of paresthesias arising from healthy axons. Muscle Nerve 23 (2000) 310-320
241. Mogyoros I., Lin C.S.-Y., Kuwabara S., Cappelen-Smith C., and Burke D. Strength-duration properties and their voltage dependence as measures of a threshold conductance at the node of Ranvier of single motor axons. Muscle Nerve 23 (2000) 1719-1726
242. Moldovan M., and Krarup C. Mechanisms of hyperpolarization in regenerated mature motor axons in cat. J. Physiol. 560 (2004) 807-819
243. Moldovan M., Alvarez S., and Krarup C. Motor axon excitability during Wallerian degeneration. Brain 132 (2009) 511-523
244. + pump in lizard axons impaled near their motor terminals. J. Neurophysiol. 70 (1993) 1874-1884
245. Muroi Y., and Chanda B. Local anesthetics disrupt energetic coupling between the voltage-sensing segments of a sodium channel. J. Gen. Physiol. 133 (2008) 1-15
246. Nakajima S., and Takahashi K. Post-tetanic hyperpolarization and electrogenic Na pump in stretch receptor neurone of crayfish. J. Physiol. 187 (1966) 105-127
247. Nashmi R., and Fehlings M.G. Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Brain Res. Rev. 38 (2001) 165-191
248. v1.3 null mutant mice. Mol. Pain 2 (2006) 33
249. v1.8. Mol. Pain 1 (2005) 24
250. Neher E., and Sakmann B. Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature 260 (1976) 799-802
251. Nielsen V.K. The peripheral nerve function in chronic renal failure. V. Sensory and motor conduction velocity. Acta Med. Scand. 194 (1973) 445-454
252. Noda M., Shimizu S., Tanabe T., Takai T., Kayano T., Ikeda T., Takahashi H., Nakayama H., Kanaoka Y., Minamino N., Kangawa K., Matsuo H., Raftery M.A., Hirose T., Inayama S., Hayashida H., Miyata T., and Numa S. Primary structure of Electrophorus electricus sodium channel deduced from cDNA sequence. Nature 312 (1984) 121-127
253. Nodera H., Bostock H., Kuwabara S., Sakamoto T., Asanuma K., Jia-Ying S., Ogawara K., Hattori N., Hirayama M., Sobue G., and Kaji R. Nerve excitability properties in Charcot-Marie-Tooth disease type 1A. Brain 127 (2004) 203-211
254. Nogajski J.H., Engel S., and Kiernan M.C. Focal and generalized peripheral nerve dysfunction in spinal cord-injured patients. J. Clin. Neurophys. 23 (2006) 273-279
255. + channels. Jpn. J. Pharmacol. 88 (2002) 365-377
256. 2+ channel gene CACNL1A4. Cell 87 (1996) 543-552
257. Panizza M., Nilsson J., Roth B.J., Rothwell J., and Hallett M. The time constants of motor and sensory peripheral nerve fibers measured with the method of latent addition. Electroencephalogr. Clin. Neurophys. 93 (1994) 147-154
258. Papazian D.M., Timpe L.C., Jan Y.N., and Jan L.Y. Alteration of voltage-dependence of Shaker potassium channel by mutations in the S4 sequence. Nature 349 (1991) 305-310
259. Pape H.C. Queer current and pacemaker: the hyperpolarization-activated cation current in neurons. Ann. Rev. Physiol. 58 (1996) 299-327
260. Park S.B., Goldstein D., Lin C.S.-Y., Krishnan A.V., Friedlander M.L., and Kiernan M.C. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J. Clin. Oncol. 27 (2009) 1243-1249
261. Park, S.B., Lin, C.S-.Y., Krishnan, A.V., Goldstein, D., Friedlander, M.L., Kiernan, M.C., Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain doi:10.1093/brain/awp219.
262. Parnas I. Differential block at high frequency of branches of a single axon innervating two muscles. J. Neurophysiol. 35 (1972) 903-914
263. Persaud N., and Strichartz G.R. Micromolar lidocaine selectively blocks propagating ectopic impulses at a distance from their site of origin. Pain 99 (2002) 333-340
264. Poliak S., and Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat. Rev. Neurosci. 4 (2003) 968-980
265. Porreca F., Lai J., Bian D., Wegert S., Ossipov M.H., Eglen R.M., Kassotakis L., Novakovic S., Rabert D.K., Sangameswaran L., and Hunter J.C. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 7640-7674
266. + channels by local anesthetics. Science 265 (1994) 1724-1728
267. + channels. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 9270-9275
268. Rakowski R.F., Gadsby D.C., and De Weer P. Stoichiometry and voltage dependence of the sodium pump in voltage-clamped, internally dialyzed squid giant axon. J. Gen. Physiol. 93 (1989) 903-941
269. Rakowski R.F., Gadsby D.C., and De Weer P. Voltage dependence of the Na/K pump. J. Membr. Biol. 155 (1997) 105-112
270. Ramchandren S., and Lewis R.A. Chronic neuropathies-chronic inflammatory demyelinating neuropathy and its variants. Front. Neurol. Neurosci. 26 (2009) 12-25
271. Rang H.P., and Ritchie J.M. On the electrogenic sodium pump in mammalian non-myelinated nerve fibres and its activation by various external cations. J. Physiol. 196 (1968) 183-221
272. Rasband M.N. It's "juxta" potassium channel!. J. Neurosci. Res. 76 (2004) 749-757
273. Rasband M.N., Trimmer J.S., Schwarz T.L., Levinson S.R., Ellisman M.H., Schachner M., and Shrager P. Potassium channel distribution, clustering, and function in remyelinating rat axons. J. Neurosci. 18 (1998) 36-47
274. Reid C.A., Berkovic S.F., and Petrou S. Mechanisms of human inherited epilepsies. Prog. Neurobiol. 87 (2009) 41-57
275. Reid G., Scholz A., Bostock H., and Vogel W. Human axons contain at least five types of voltage-dependent potassium channel. J. Physiol. 518 (1999) 681-696
276. Renganathan M., Cummins T.R., and Waxman S.G. Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. J. Neurophysiol. 86 (2001) 629-640
277. Rhodes T.H., Lossin C., Vanoye C.G., Wang D.W., and George Jr. A.L. Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 11147-11152
278. Ringel S.P., Murphy J.R., Alderson M.K., Bryan W., England J.D., Miller R.G., Petajan J.H., Smith S.A., Roelofs R.I., Ziter F., Lee M.Y., Brinkmann J.R., Almada A., Gappmaier E., Graves J., Herbelin L., Mendoza M., Mylar D., Smith P., and Yu P. The natural history of amyotrophic lateral sclerosis. Neurology 43 (1993) 1316-1322
279. Ritchie J., and Straub R. The hyperpolarization which follows activity in mammalian non-medullated fibres. J. Physiol. 136 (1957) 80-97
280. Ritchie J.M., and Rogart R.B. Density of sodium channels in mammalian myelinated nerve fibers and nature of the axonal membrane under the myelin sheath. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 211-215
281. + channel isoform. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 8170-8174
282. Rogawski M.A., and Loscher W. The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 5 (2004) 553-564
283. Rogers M., Tang L., Madge D.J., and Stevens E.B. The role of sodium channels in neuropathic pain. Semin. Cell Dev. Biol. 17 (2006) 571-581
284. Roper J., and Schwarz J.R. Heterogeneous distribution of fast and slow potassium channels in myelinated rat nerve fibres. J. Physiol. 416 (1989) 93-110
285. Rosenbluth J. Intramembranous particle distribution at the node of Ranvier and adjacent axolemma in myelinated axons of the frog brain. J. Neurocytol. 5 (1976) 731-745
286. Roy M.L., and Narahashi T. Differential properties of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons. J. Neurosci. 12 (1992) 2104-2111
287. v1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J. Physiol. 550 (2003) 921-926
288. Rush A.M., Brau M.E., Elliott A.A., and Elliott J.R. Electrophysiological properties of sodium current subtypes in small cells from adult rat dorsal root ganglia. J. Physiol. 511 (1998) 771-789
289. Rush A.M., Dib-Hajj S.D., Liu S., Cummins T.R., Black J.A., and Waxman S.G. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8245-8250
290. v1.9 sodium current in mouse DRG neurons via G-proteins. Brain Res. 1023 (2004) 264-271
291. +-ATPase activity by delta-aminolevulinic acid. Neurochem. Res. 8 (1983) 1407-1415
292. Safronov B.V., Kampe K., and Vogel W. Single voltage-dependent potassium channels in rat peripheral nerve membrane. J. Physiol. 460 (1993) 6756-6791
293. + currents in neurones: types, physiological roles and modulation. Trends Neurosci. 19 (1996) 150-154
294. Sangameswaran L., Delgado S.G., Fish L.M., Koch B.D., Jakeman L.B., Stewart G.R., Sze P., Hunter J.C., Eglen R.M., and Herman R.C. Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J. Biol. Chem. 271 (1996) 5953-5956
295. Sangameswaran L., Fish L.M., Koch B.D., Rabert D.K., Delgado S.G., Ilnicka M., Jakeman L.B., Novakovic S., Wong K., Sze P., Tzoumaka E., Stewart G.R., Herman R.C., Chan H., Eglen R.M., and Hunter J.C. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J. Biol. Chem. 272 (1997) 14805-14809
296. Scholz A., Reid G., Vogel W., and Bostock H. Ion channels in human axons. J. Neurophysiol. 70 (1993) 1249-1274
297. Schwarz J.R., and Grigat G. Phenytoin and carbamazepine: potential- and frequency-dependent block of Na currents in mammalian myelinated nerve. Epilepsia 30 (1989) 286-294
298. Schwarz J.R., Reid G., and Bostock H. Action potentials and membrane currents in the human node of Ranvier. Pflugers Arch. 430 (1995) 283-292
299. + current regulating excitability in the rat node of Ranvier. J. Physiol. 573 (2006) 17-34
300. Segal M.M., and Douglas A.F. Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin. J. Neurophysiol. 77 (1997) 3021-3034
301. Sherratt R.M., Bostock H., and Sears T.A. Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres. Nature 283 (1980) 570-572
302. Siegelbaum S.A., and Koester J. Ion channels. In: Kandel E.R., Schwartz J.H., and Jessell T.M. (Eds). Principles of Neural Science (1991), Elsevier Science, New York 66-79
303. Sima A.A. Metabolic alterations of peripheral nerve in diabetes. Semin. Neurol. 16 (1996) 129-137
304. Sinha S., Newsom-Davis J., Mills K., Byrne N., Lang B., and Vincent A. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet 338 (1991) 75-77
305. Sleeper A.A., Cummins T.R., Dib-Hajj S.D., Hormuzdiar W., Tyrrell L., Waxman S.G., and Black J.A. Changes in expression of two tetrodotoxin-resistant sodium channels and their currents in dorsal root ganglion neurons after sciatic nerve injury but not rhizotomy. J. Neurosci. 20 (2000) 7279-7289
306. Smart S.L., Lopantsev V., Zhang C.L., Robbins C.A., Wang H., Chiu S.Y., Schwartzkroin P.A., Messing A., and Tempel B.L. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 20 (1998) 809-819
307. Smith R.D., and Goldin A.L. Functional analysis of the rat I sodium channel in xenopus oocytes. J. Neurosci. 18 (1998) 811-820
308. Spadoni F., Hainsworth A.H., Mercuri N.B., Caputi L., Martella G., Lavaroni F., Bernardi G., and Stefani A. Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons. Neuroreport 13 (2002) 1167-1170
309. Spampanato J., Aradi I., Soltesz I., and Goldin A.L. Increased neuronal firing in computer simulations of sodium channel mutations that cause generalized epilepsy with febrile seizures plus. J. Neurophysiol. 91 (2004) 2040-2050
310. Stefoski D., Davis F.A., Faut M., and Schauf C.L. 4-Aminopyridine improves clinical signs in multiple sclerosis. Ann. Neurol. 21 (1987) 71-77
311. Stevens M.J., Lattimer S.A., Kamijo M., Van Huysen C., Sima A.A., and Greene D.A. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia 36 (1993) 608-614
312. Stohr M. Activity-dependent variations in threshold and conduction velocity of human sensory fibers. J. Neurol. Sci. 49 (1981) 47-54
313. Stuhmer W., Conti F., Suzuki H., Wang X.D., Noda M., Yahagi N., Kubo H., and Numa S. Structural parts involved in activation and inactivation of the sodium channel. Nature 339 (1989) 597-603
314. Stys P.K. General mechanisms of axonal damage and its prevention. J. Neurol. Sci. 233 (2005) 3-13
315. Stys P.K., and Waxman S.G. Activity-dependent modulation of excitability: implications for axonal physiology and pathophysiology. Muscle Nerve 17 (1994) 969-974
316. Stys P.K., Ransom B.R., Waxman S.G., and Davis P.K. Role of extracellular calcium in anoxic injury of mammalian central white matter. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 4212-4216
317. 2+ exchanger. J. Neurosci. 12 (1992) 430-439
318. + conductance in rat optic nerve axons. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6976-6980
319. + channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6384-6389
320. Sugawara T., Mazaki-Miyazaki E., Fukushima K., Shimomura J., Fujiwara T., Hamano S., Inoue Y., and Yamakawa K. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 58 (2002) 1122-1124
321. Sugiura Y., Makita N., Li L., Noble P.J., Kimura J., Kumagai Y., Soeda T., and Yamamoto T. Cold induces shifts of voltage dependence in mutant SCN4A, causing hypokalemic periodic paralysis. Neurology 61 (2003) 914-918
322. Sun X.P., Schlichter L.C., and Stanley E.F. Single-channel properties of BK-type calcium-activated potassium channels at a cholinergic presynaptic nerve terminal. J. Physiol. 518 (1999) 639-651
323. Susuki K., Rasband M.N., Tohyama K., Koibuchi K., Okamoto S., Funakoshi K., Hirata K., Baba H., and Yuki N. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci. 27 (2007) 3956-3967
324. Suzuki H., Beckh S., Kubo H., Yahagi N., Ishida H., Kayano T., Noda M., and Numa S. Functional expression of cloned cDNA encoding sodium channel III. FEBS Lett. 228 (1988) 195-200
325. Taddese A., and Bean B.P. Subthreshold sodium current from rapidly inactivating sodium channels drives spontaneous firing of tuberomammillary neurons. Neuron 33 (2002) 587-600
326. Takigawa T., Alzheimer C., Quasthoff S., and Grafe P. A special blocker reveals the presence and function of the hyperpolarization-activated cation current IH in peripheral mammalian nerve fibres. Neuroscience 82 (1998) 631-634
327. +-pump activity in rat myelinated nerve fibers. Neuroreport 11 (2000) 2547-2551
328. + currents in human neuropathy and motor neuron disease estimated by latent addition. Clin. Neurophys. 117 (2006) 2451-2458
329. + channel expression increases in dorsal root ganglion neurons in the carrageenan inflammatory pain model. Neuroreport 9 (1998) 967-972
330. Tatulian L., and Brown D.A. Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells. J. Physiol. 549 (2003) 57-63
331. + conductance in human cutaneous afferents. J. Physiol. 453 (1992) 575-589
332. Tegner R., and Brismar T. Experimental uremic neuropathy. Part 1. Decreased nerve conduction velocity in rats. J. Neurol. Sci. 65 (1984) 29-36
333. Thomas R.C. Electrogenic sodium pump in nerve and muscle cells. Physiol. Rev. 52 (1972) 563-594
334. + conductance in peripheral axons. Muscle Nerve 28 (2003) 212-217
335. Toledo-Aral J.J., Moss B.L., He Z.J., Koszowski A.G., Whisenand T., Levinson S.R., Wolf J.J., Silos-Santiago I., Halegoua S., and Mandel G. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 1527-1532
336. Tremont-Lukats I.W., Challapalli V., McNicol E.D., Lau J., and Carr D.B. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth. Analg. 101 (2005) 1738-1749
337. Trimmer J.S., Cooperman S.S., Tomiko S.A., Zhou J.Y., Crean S.M., Boyle M.B., Kallen R.G., Sheng Z.H., Barchi R.L., Sigworth F.J., Goodman R.H., Agnew W.S., and Mandel G. Primary structure and functional expression of a mammalian skeletal muscle sodium channel. Neuron 3 (1989) 33-49
338. Tzoumaka E., Tischler A.C., Sangameswaran L., Eglen R.M., Hunter J.C., and Novakovic S.D. Differential distribution of the tetrodotoxin sensitive rPN4/NaCh6/SCN8A sodium channel in the nervous system. J. Neurosci. Res. 60 (2000) 37-44
339. Ulzheimer J.C., Peles E., Levinson S.R., and Martini R. Altered expression of ion channel isoforms at the node of Ranvier in P0-deficient myelin mutants. Mol. Cell. Neurosci. 25 (2004) 83-94
340. Vagg R., Mogyoros I., Kiernan M.C., and Burke D. Activity-dependent hyperpolarization of human motor axons produced by natural activity. J. Physiol. 507 (1998) 919-925
341. Van Asseldonk J.-T.H., Franssen H., Van den Berg-Vos R.M., Wokke J.H.J., and Van den Berg L.H. Multifocal motor neuropathy. Lancet Neurol. 4 (2005) 309-319
342. Van den Neucker K., Vanderstraeten G., and Vanholder R. Peripheral motor and sensory nerve conduction studies in haemodialysis patients. A study of 54 patients. Electromyogr. Clin. Neurophysiol. 38 (1998) 467-474
343. van Diemen H.A., Polman C.H., van Dongen T.M., van Loenen A.C., Nauta J.J., Taphoorn M.J., van Walbeek H.K., and Koetsier J.C. The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study. Ann. Neurol. 32 (1992) 123-130
344. +-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann. Neurol. 54 (2003) 360-366
345. Viala K., Renie L., Maisonobe T., Behin A., Neil A., Leger J.M., and Bouche P. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 127 (2004) 2010-2017
346. Vincent A., McConville J., Farrugia M.E., Bowen J., Plested P., Tang T., Evoli A., Matthews I., Sims G., Dalton P., Jacobson L., Polizzi A., Blaes F., Lang B., Beeson D., Willcox N., Newsom-Davis J., and Hoch W. Antibodies in myasthenia gravis and related disorders. Ann. N. Y. Acad. Sci. 998 (2003) 324-335
347. Vogel W., and Schwarz J.R. Voltage-clamp studies on axons: macroscopic and single-channel currents. In: Waxman S.G., Kocsis J.D., and Stys P.K. (Eds). The Axon: Structure, Function and Pathophysiology (1995), Oxford University Press 257-280
348. Vucic S., and Kiernan M.C. Axonal excitability properties in amyotrophic lateral sclerosis. Clin. Neurophys. 117 (2006) 1458-1466
349. Vucic S., and Kiernan M.C. Pathophysiologic insights into motor axonal function in Kennedy disease. Neurology 69 (2007) 1828-1835
350. Vucic S., Krishnan A.V., and Kiernan M.C. Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 78 (2007) 1202-1208
351. +-channel beta1 subunit gene SCN1B. Nat. Genet. 19 (1998) 366-370
352. + channels in terminal and juxtaparanodal regions of neurons. Nature 365 (1993) 75-79
353. Waxman S.G. Sodium channel blockers and axonal protection in neuroinflammatory disease. Brain 128 (2005) 5-6
354. Waxman S.G. Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat. Rev. Neurosci. 7 (2006) 932-941
355. Waxman S.G. Channel, neuronal and clinical function in sodium channelopathies: from genotype to phenotype. Nat. Neurosci. 10 (2007) 405-409
356. Waxman S.G., Kocsis J.D., and Black J.A. Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J. Neurophysiol. 72 (1994) 466-470
357. Waxman S.G., and Ritchie J.M. Molecular dissection of the myelinated axon. Ann. Neurol. 33 (1993) 121-136
358. Webster R.G., Brain K.L., Wilson R.H., Grem J.L., and Vincent A. Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels. Br. J. Pharmacol. 146 (2005) 1027-1039
359. Weiss G. Sur la possibilité de rendre comparables entre eux les appareils servant l'excitation électrique. Arch. Ital. Biol. 35 (1901) 413-446
360. Welt L.G., Sachs J.R., and McManus T.J. An ion transport defect in erythrocytes from uraemic subjects. Trans. Ass. Am. Phys. 77 (1964) 169-181
361. + channel subtypes in central neurons. Neuron 3 (1989) 695-704
362. Whitaker W.R., Faull R.L., Waldvogel H.J., Plumpton C.J., Emson P.C., and Clare J.J. Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res. Mol. Brain Res. 88 (2001) 37-53
363. Wickenden A.D., Yu W., Zou A., Jegla T., and Wagoner P.K. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol. Pharmacol. 58 (2000) 591-600
364. Wilson R.H., Lehky T., Thomas R.R., Quinn M.G., Floeter M.K., and Grem J.L. Acute oxaliplatin-induced peripheral nerve hyperexcitability. J. Clin. Oncol. 20 (2002) 1767-1774
365. Wood J.G., Jean D.H., Whitaker J.N., McLaughlin B.J., and Albers R.W. Immunocytochemical localization of the sodium, potassium activated ATPase in knifefish brain. J. Neurocytol. 6 (1977) 571-581
366. + channel expressed in a stable mammalian cell line. Pflugers Arch. 441 (2001) 425-433
367. Yang Q., Kaji R., Hirota N., Kojima Y., Takagi T., Kohara N., Kimura J., Shibasaki H., and Bostock H. Effect of maturation on nerve excitability in an experimental model of threshold electrotonus. Muscle Nerve 23 (2000) 498-506
368. Yang Y., Wang Y., Li S., Xu Z., Li H., Ma L., Fan J., Bu D., Liu B., Fan Z., Wu G., Jin J., Ding B., Zhu X., and Shen Y. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet. 41 (2004) 171-174
369. Yu F.H., Mantegazza M., Westenbroek R.E., Robbins C.A., Kalume F., Burton K.A., Spain W.J., McKnight G.S., Scheuer T., and Catterall W.A. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 9 (2006) 1142-1149
370. Zhou L., Messing A., and Chiu S.Y. Determinants of excitability at transition zones in Kv1.1-deficient myelinated nerves. J. Neurosci. 19 (1999) 5768-5781
371. Zhou L., Zhang C.L., Messing A., and Chiu S.Y. Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves. J. Neurosci. 18 (1998) 7200-7215
372. Zhu X., and Eichberg J. A myo-inositol pool utilized for phosphatidylinositol synthesis is depleted in sciatic nerve from rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 9818-9822
373. Zielasek J., Martini R., Suter U., and Toyka K.V. Neuromyotonia in mice with hereditary myelinopathies. Muscle Nerve 23 (2000) 696-701